Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 3Phase 3 2Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 24OTHER 9OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Hydromorphone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Cancer Pain × Clear all
NCT04785768 2025-05-22

IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration

Fujian Cancer Hospital

Phase 3 Completed
1,372 enrolled

Cancer Pain

NCT03375515 2021-03-08

PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain

Fujian Cancer Hospital

Phase 3 Completed
214 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡